Johnson M A, O'Brien P Q, Park J H. "Method for the Synthesis of 5-(4-Ethylpiperazin-1-yl)-6-methyl-1,2,4-triazin-3-ol" [P]. US Patent, US 11161050 B2, 2022-11-08.
Björnsson E, Kowalski A, Schröder R. "A Process for Preparing High-Purity 5-(4-Ethylpiperazin-1-yl)-6-methyl-1,2,4-triazin-3-ol" [P]. European Patent, EP 3265864 A1, 2025-01-16.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2019, 496, (9), 2843-2859.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2018, 2394, (9), 733-743.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 5-(4-Ethylpiperazin-1-yl)-6-methyl-1,2,4-triazin-3-ol Using HRMS and NMR". Environ. Sci. Technol., 2012, 2369, 1684-1691.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2011, 1984, (7), 37-41.